REVIEW
Published on 01 Aug 2013
Mechanisms regulating resistance to inhibitors of topoisomerase II
doi 10.3389/fphar.2013.00089
- 10,474 views
- 76 citations
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Therapeutic Resistance in Cancer: Mechanisms, Insights and Progress
Therapeutic Resistance in Cancer: Mechanisms, Insights and Progress
35k
Total downloads
168k
Total views and downloads
Articles
REVIEW
Published on 16 May 2013
Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
doi 10.3389/fonc.2013.00120
- 22,261 views
- 249 citations
REVIEW
Published on 07 May 2013
Therapy’s Shadow: A Short History of the Study of Resistance to Cancer Chemotherapy
doi 10.3389/fphar.2013.00058
- 7,612 views
- 17 citations
REVIEW
Published on 30 Apr 2013
Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy
doi 10.3389/fphar.2013.00056
- 8,267 views
- 84 citations
ORIGINAL RESEARCH
Published on 28 Mar 2013
Association of the epithelial-to-mesenchymal transition phenotype with responsiveness to the p21-activated kinase inhibitor, PF-3758309, in colon cancer models
doi 10.3389/fphar.2013.00035
- 8,420 views
- 33 citations
ORIGINAL RESEARCH
Published on 22 Mar 2013
Tumor P-Glycoprotein Correlates with Efficacy of PF-3758309 in in vitro and in vivo Models of Colorectal Cancer
doi 10.3389/fphar.2013.00022
- 8,310 views
- 33 citations
MINI REVIEW
Published on 14 Mar 2013
Mechanisms and insights into drug resistance in cancer
doi 10.3389/fphar.2013.00028
- 52,847 views
- 574 citations
PERSPECTIVE
Published on 11 Mar 2013
Physician Recruitment of Patients to Non-Therapeutic Oncology Clinical Trials: Ethics Revisited
doi 10.3389/fphar.2013.00025
- 6,208 views
- 10 citations
MINI REVIEW
Published on 27 Feb 2013
Resistance to PARP-Inhibitors in Cancer Therapy
doi 10.3389/fphar.2013.00018
- 13,239 views
- 90 citations
REVIEW
Published on 13 Feb 2013
Erlotinib Resistance in Lung Cancer: Current Progress and Future Perspectives
doi 10.3389/fphar.2013.00015
- 19,121 views
- 63 citations
ORIGINAL RESEARCH
Published on 12 Feb 2013
Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient
doi 10.3389/fphar.2013.00009
- 4,317 views
- 5 citations
MINI REVIEW
Published on 11 Feb 2013
The Molecular Chaperone GRP78/BiP in the Development of Chemoresistance: Mechanism and Possible Treatment
doi 10.3389/fphar.2013.00010
- 12,478 views
- 117 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore